Member Info for Magsy18

Yes, there seems to be an unexplainable difference between our mcap and ODX/AVCT. You aren’t making a new argument, people here have been proclaiming the GDR rerate to bring us inline with the other two for months. It hasn’t happened and nor is there any reason to believe that it will unless of course we get some transformational news.

Finncap are our broker, they have been mentioning us fairly regularly in articles since last May. It means nothing.

The main reason to invest into GDR over the others is that given our mcap, IF significant sales do come in then we would probably rise the most.

IF is the word though. We launched the product last May and struggled to get approvals in any of our target markets. When we did get approval in one our targets, South Africa, we failed to sell a bean.

The biggest hopes we have right now are a low double digit contract in an EU country, which seems to be taking a long time to conclude and the potential of a commercial agreement with BC which we currently do not have.

The BS being spouted by the rampers about the UK is unlikely to materialise as our CEO has repeatedly said that the chance of success is low and therefore it isn’t a target.

Short term, improvement in sentiment may provide some respite here but long term the only way this gets £1+ again is if we confirm some sales.

Why haven’t we had a slice from the UK in the 8 months since the product was launched? Why now?

DB has stated more than once that the UK is not a market GDR are targeting.

We have been in the same position in relation to AVCT and ODX for not far off a year. Why would it rerate now?

Uddin you also said...

RE: GDR will be on the takeover list23 Jan 2021 13:07
FDA Approval, so ready to go in US.

Oops!

Rocket, how much in sales revenues do you think we will need to reach your 500p and 1000p predictions?

Odd that the weirdos, as you call them, are the ones posting the facts.

The ‘normal’ people are spamming the same links and outright lying in posts.

I’m happy to remain a weirdo.

They have been on the list for over a month.

Besides, as I said, the half of my holding I sold in December, I bought back with over the last few days. Some of those ‘chunky buys’ were actually mine.

I think that next week could well be one of the better weeks we have had in a while.

I do want people to see the link. It explicitly says that we aren’t approved by the FDA.

Suggesting I have shorted GDR is a huge compliment. If it’s true I will have made a fortune since May last year.

Also finncap has named us plenty of times, they are GDR’s joint broker, it’s in their best interest to.

You’re a liar. Why state we are FDA approved when we aren’t?

And there you have it. Two brand new rampers who have just outed themselves as lying scumbags.

In the page uddin links it explicitly says that genedrive is not FDA approved. As per the 16th Dec RNS, we already know that the FDA acknowledged our request to distribute whilst we await approval. This is not new information, don’t try and suggest it is.

Thanks for making it so easy!

Erm dreamless?! Derampers...

All popular share have dreamless. Sometimes there is a rise, sometimes there isn’t. The existence of derampers doesn’t signify anything in regards to the future.

Even the long term optimists here know that this only moves significantly north if we get sales.

I wouldn’t worry too much about shorters, they’ve made a killing on GDR.

Also, the comparisons with NCYT aren’t valid until we have sales. NCYT had some decent sales when it dipped last year which of course helps underpin any rise. The big gain was after the huge UK contract.

We have seen it many times here, GDR will rise and it will fall in the short term but over time it will drop unless we secure sales. It was as simple as that back in May and it’s as simple as that now.

People who have tried to make others sell over the last 7 months should actually be applauded as they would have saved them some cash.

Conversely, the people who have tried to get people to buy would actually have lost people money.

Are you expecting a £150m+ contract here at GDR then sharehunter?

Your previous predictions about GDR have been interesting. Delusional indeed.

RE: Where did everyone go18 Aug 2020 20:44
I can see GDR reaching Atleast £4 by the end of the year after sales figures. What a load of nonsense

RE: Shambles10 Sep 2020 22:16
You can’t compare with genedrive tho. Genedrive is my main hold. It will multi bag before Christmas. This will be very lucky to reach 40p by then. Kicking myself for this one. I hope I don’t end up taking a 50% loss like u said haha

It was almost certainly a BGF sell. It would take them under 8% so we will find out early next week I guess!